Real-World Registry Study on Clinical Analgesic Effect of Acetylaconitine Tablets

Ke Ma

Status: Enrolling

Conditions: Chronic Pain

Study type: Observational

Funder types: Other

Identifiers

NCT05687929

XH-22-008

Details and patient eligibility

About

1. To observe the clinical analgesic effect, safety and adverse reactions of acetylaconitine.
2. To study and analyze the main influencing factors of the acetylaconitine tablets.

Full description

The outpatients/inpatients meeting the criteria are included into this study after signing the Informed Consent Form. The patients received 5 visits in total, which take place after the patients are included into the real-world study, on the 3rd day after enrollment and at the 1st, 4th, 8th and 12th weeks thereafter, in the form of outpatient follow-up, telephone follow-up and APP follow-up.

Enrollment: 3,500 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with chronic pain > 1 month and VAS > 40 mm Patients who can take the acetylaconitine tablets orally

Exclusion criteria

• Patients who cannot communicate or receive follow-up Patients allergic to acetylaconitine Patients who have taken the acetylaconitine drugs orally